TY - JOUR
T1 - Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder
T2 - A Population-Based Study
AU - Cattrini, Carlo
AU - Cerbone, Luigi
AU - Rubagotti, Alessandra
AU - Zinoli, Linda
AU - Latocca, Maria Maddalena
AU - Messina, Carlo
AU - Zanardi, Elisa
AU - Boccardo, Francesco
PY - 2019/8/1
Y1 - 2019/8/1
N2 - This study retrospectively analyzed the United States Surveillance, Epidemiology, and End Results (SEER) Database. We found that the use of chemotherapy is associated with better outcome in patients with non-metastatic small-cell neuroendocrine carcinoma of the bladder. We also found that patients with T2 disease treated with surgery show better survival compared with those treated with radiotherapy.
AB - This study retrospectively analyzed the United States Surveillance, Epidemiology, and End Results (SEER) Database. We found that the use of chemotherapy is associated with better outcome in patients with non-metastatic small-cell neuroendocrine carcinoma of the bladder. We also found that patients with T2 disease treated with surgery show better survival compared with those treated with radiotherapy.
KW - Neuroendocrine bladder cancer
KW - Prognostic variables
KW - SCCB
KW - SEER
KW - Small-cell bladder cancer
UR - http://www.scopus.com/inward/record.url?scp=85066870123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066870123&partnerID=8YFLogxK
U2 - 10.1016/j.clgc.2019.03.010
DO - 10.1016/j.clgc.2019.03.010
M3 - Article
C2 - 31160193
AN - SCOPUS:85066870123
VL - 17
SP - e724-e732
JO - Clinical Genitourinary Cancer
JF - Clinical Genitourinary Cancer
SN - 1558-7673
IS - 4
ER -